Introduction
During their lifetime, bacteria and archaea face the constant threat of invading foreign DNA, mainly mobile genetic elements such as phages, plasmids, transposons and genomic islands. A gain of novel genetic traits can have a beneficial or detrimental consequence on the host. For example, the horizontal transfer of genetic elements contributes largely to the acquisition of antibiotic resistance by environmental and clinical bacteria. In addition, virulence determinants can be acquired, leading to toxigenic conversion of bacterial strains. A particular threat to bacteria and archaea are their viral predators. The global phage population is genetically diverse, their abundance exceeds bacterial numbers by an order of magnitude and an estimated 10 25 infections occur every second (Hendrix, 2003; Weinbauer, 2004; Wommack and Colwell, 2000) . Therefore, an arms race is said to exist between prokaryotes and their viruses and to survive phage infection, and control the flow of genetic information, bacteria and archaea have evolved diverse defense strategies (Labrie et al., 2010) .
To counteract viral infections, eukaryotic organisms launch an immune response consisting of innate (or non-specific) and adaptive (or specific) mechanisms. Most viral infections are halted by the first line of innate immune defenses that are continuously active in the host without exposure to any virus. In cases when viral replication outpaces innate defenses, the host then mounts the adaptive response. Similar defense strategies against viral infection apply to microorganisms like bacteria and archaea (Bikard and Marraffini, 2012) . Innate immunity against phages can be considered to involve the mechanisms of abortive infection, mutation of host receptors or restriction/modification of the incoming foreign DNA. However, in most cases these systems are not truly innate since they also display a degree of specificity. Recently, CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) has been discovered as an adaptive defense mechanism against phages (reviewed recently by Bhaya et al. (2011); Deveau et al. (2010) ; Horvath and Barrangou (2010) ; Marraffini and Sontheimer (2010) ; Terns and Terns (2011); van der Oost et al. (2009); Wiedenheft et al. (2012) ). The system is heritable, widespread among bacteria and archaea and active in immunity against various mobile genetic elements.
CRISPR-Cas immunity is mediated by RNA and protein components that function together in ribonucleoprotein complexes. The CRISPR-Cas immune strategy consists of an adaptive phase with acquisition of memory, a biogenesis phase to generate the guide RNA components and a phase of interference of the invading cognate nucleic acids by ribonucleoprotein complexes consisting of Cas proteins and the guide RNAs ( Fig. 1) (Bhaya et al., 2011; Deveau et al., 2010; Horvath and Barrangou, 2010; Marraffini and Sontheimer, 2010; Terns and Terns, 2011; van der Oost et al., 2009; Wiedenheft et al., 2012) . ''Adaptive'' refers here to the specificity of the immune response that is customized to a particular foreign invader. A key feature in the adaptation phase of CRISPR-Cas is memory, whereby a repeated infection by the same phage is stopped immediately by the specific response. The loci are commonly composed of an array of repeat-spacer sequences encoding the RNA components and an operon of cas genes encoding the protein components. The array consists of a leader sequence followed by a succession of short identical repeats regularly interspaced by short spacer sequences. The spacer sequences originate from previous encounters with foreign genetic material and thus function as a memory bank that will recognize the same genetic encounter upon a repeated infection. Briefly, CRISPR-Cas immunity operates as follows. Upon infection with the genetic intruder, a short sequence of the invading DNA (termed a protospacer, proposed to be now termed precursor-spacer In adaptation, phage infection is recognized by Cas proteins (presumably the core Cas1 and Cas2) and a short sequence of the phage DNA (termed a protospacer, proposed to be now termed precursor-spacer or pre-spacer ) is added to the leader end of the CRISPR array, resulting in a new spacer sequence and a duplicated repeat. Represented are the cas operon encoding the Cas proteins and the closely associated CRISPR array, composed of the leader sequence followed by a series of repeats-spacer units. (B) Transcription of the CRISPR array from a promoter within the leader sequence results in a precursor CRISPR RNA (pre-crRNA) transcript. The pre-crRNA is matured into individual crRNAs by a process involving Cas proteins. (C) The mature crRNAs form a ribonucleoprotein complex, which targets nucleic acids that are complementary to the spacer sequence in the crRNAs. In some cases a separate Cas nuclease (orange) is recruited, resulting in interference and destruction of the nucleic acid target. The general schematic is based on the type I system, and differences exist between the type I, II and III. For details, see the text.
or pre-spacer ) is inserted in the CRISPR array as a spacer sequence. The repeat-spacer array is transcribed from a promoter region present in the leader sequence as a precursor CRISPR RNA (pre-crRNA) molecule. The pre-crRNA undergoes one or more maturation events to generate the individual mature crRNAs that are composed each of repeat portion(s) and a targeting spacer portion. The mature crRNAs then function as guide RNAs that direct the Cas protein(s), in a sequence-specific manner, to cleave the invading nucleic acids.
The first description of CRISPR elements dates back to 1987 when Ishino et al. (1987) discovered a series of short palindromic sequences regularly repeated and separated by short unique sequences on the genome of Escherichia coli. Later, CRISPR arrays were also detected in archaea (Groenen et al., 1993; Masepohl et al., 1996; Mojica et al., 2005) and three independent studies identified the viral and plasmid source of spacer sequences (Bolotin et al., 2005; Mojica et al., 2005; Pourcel et al., 2005) . The observation of spacers matching foreign genetic elements, combined with a detailed bioinformatic analysis of the Cas proteins revealing putative nuclease and helicase domains, led to the proposal that CRISPR-Cas functions as an RNA-mediated adaptive immune system (Makarova et al., 2006) . In 2007, CRISPR-Cas activity in adaptive immunity against phages was demonstrated for the first time in the laboratory with infection experiments of the Gram-positive lactic acid bacterium Streptococcus thermophilus by lytic phages (Barrangou et al., 2007) . The study raised considerable attention in the scientific community, which recognized the potential to use the adaptive feature of CRISPR-Cas immunity as a new tool to control phage infection in the dairy industry (Barrangou and Horvath, 2012) . Since 2007, there has also been an exponential interest in understanding how the immunity functions at the molecular level. Considerable efforts from a community of microbiologists and structural biologists have led to significant novel findings in the mechanisms of crRNA biogenesis (Brouns et al., 2008; Carte et al., 2008; Deltcheva et al., 2011; Hatoum-Aslan et al., 2011; Haurwitz et al., 2010; Nam et al., 2012b; Przybilski et al., 2011) and interference with nucleic acids Jinek et al., 2012; .
The CRISPR-Cas systems have undergone rapid evolution and a recent classification of the systems led to a distribution into three types (i.e. I, II and III) further sub-grouped into several sub-types (i.e. I-A to I-F, II-A and II-B, III-A and III-B) characterized by Cas protein signatures (e.g. Cas3, Cas9, Cas10 for types I, II and III). Although the three systems share common principles in the immunity steps, they utilize distinct molecular mechanisms for crRNA biogenesis and interference. For example, in the bacterial and archaeal systems I and III, Cas6-like proteins are endoribonucleases that cleave pre-crRNA (Brouns et al., 2008; Carte et al., 2008; Ebihara et al., 2006; Hatoum-Aslan et al., 2011; Haurwitz et al., 2010; Przybilski et al., 2011; Richter et al., 2012b) , while in the bacterial type II system, processing of the precursor molecule requires the concerted action of a small trans-activating RNA (tracrRNA), the protein Cas9 (formerly named Csn1) and the nonCas endoribonuclease III (RNase III) acting as a dicing effector (Deltcheva et al., 2011) . Furthermore, the mature crRNAs in type I and III systems guide a complex of Cas proteins, referred to as the Cascade-like complexes, to the cognate nucleic acids (invading protospacer) for subsequent cleavage by an effector Cas endonuclease Howard et al., 2011; Jore et al., 2011; Lintner et al., 2011; Mulepati and Bailey, 2011; Sinkunas et al., 2011; Wiedenheft et al., 2011a; Wiedenheft et al., 2011b) . In system II, no complex of Cas proteins is implicated. Instead, a dual-RNA structure formed between the mature forms of tracrRNA and crRNA guides the single protein Cas9 to cleave the DNA (Jinek et al., 2012) .
Despite major advances in our understanding of the crRNA biogenesis and interference steps, until recently there has been little insight into the acquisition of immunity, whereby new spacers are added to the CRISPR arrays. A number of critical studies have begun to elucidate details of the acquisition process, which will be the focus of this minireview.
How is new information acquired?
2012 has seen major advances in our understanding of spacer acquisition, whereby the repeat is duplicated and a new spacer is added at the leader end of the array. The first key experimental demonstration of spacer incorporation into CRISPR arrays was in 2007 in the type II-A system of Streptococcus thermophilus (Barrangou et al., 2007) . Barrangou et al. challenged S. thermophilus with two phages, either separately or in combination, and selected for phage-resistant survivors. The CRISPR arrays in these strains had acquired between one and four spacers from the invading phages at the leader end of the array. The two bacteriophages were unique, yet shared regions of sequence identity and cross-resistance against both phages was observed when one spacer had sequence similarity to protospacers in both phages. Furthermore, spacers were incorporated from either the sense or antisense strand of the phage genome and there seemed to be no preference for which part of the phage genome was selected for integration in the arrays. The same group identified a short sequence adjacent to the protospacer target , later termed the protospacer adjacent motif (PAM), that was required for interference and possibly acquisition. Later work in S. thermophilus provided similar evidence that spacers could be acquired from plasmids carrying antibiotic resistance genes .
Many bioinformatic and metagenomic studies have also provided further evidence of the process of adaptation (Andersson and Banfield, 2008; Horvath et al., 2009; Horvath et al., 2008; Pride et al., 2012; Pride et al., 2011; Tyson and Banfield, 2008) . These studies indicated that new spacers are added at the leader end of the array. However, this dogma was recently challenged when acquisition of new spacers internal to a CRISPR array was observed in wet laboratory experiments in Sulfolobus solfataricus (Erdmann and Garrett, 2012) . Bioinformatic analyses have shown that CRISPR arrays are rapidly evolving in many bacteria. On this basis, the CRISPR-Cas loci can be used as a powerful phylogenetic marker to study the evolution of closely related strains over short time scales, as exemplified in Yersinia pestis (Drevet and Pourcel, 2012; Grissa et al., 2008; Grissa et al., 2007a; Grissa et al., 2007b; Vergnaud et al., 2007) . There are exceptions however; the CRISPRs of E. coli have evolved very slowly and cannot be used effectively for studying recent evolutionary histories (Touchon et al., 2011; Touchon and Rocha, 2010) . Strong evidence for the rapid ability of CRISPR-Cas systems to respond to viral infection and acquire spacers comes from metagenomic analyses of the population dynamics of mobile genetic elements, such as viruses, and bacteria in both environmental and human niches (Andersson and Banfield, 2008; Pride et al., 2012; Pride et al., 2011; Tyson and Banfield, 2008) . However, with the exception of S. thermophilus (Barrangou et al., 2007; Deveau et al., 2008) , spacer addition in other bacteria or in archaea was not reported in the laboratory until 2012. Spacer acquisition has now been detected under laboratory conditions in the E. coli type I-E (Datsenko et al., 2012; Swarts et al., 2012; Yosef et al., 2012) , Pseudomonas aeruginosa type I-F (Cady et al., 2012) , Streptococcus agalactiae type II-A (Lopez-Sanchez et al., 2012) and S. solfataricus type I and III-B (Erdmann and Garrett, 2012) systems. The studies of the E. coli type I-E system have provided the greatest insight into the underlying mechanisms of spacer integration and will be the focus of the remainder of the review. The current model of this process is summarized in Fig. 2 . Based on their conservation, tight genomic co-association and their predicted biochemical functions, Makarova et al. (2006) proposed that spacer integration was mediated by Cas1 in cooperation with Cas2. Overexpression of only Cas1 and Cas2 by Yosef et al. (2012) led to the incorporation of spacers derived from the expression plasmid and to a lesser extent, the chromosome. Both proteins were required since expression of either Cas1 or Cas2 alone did not stimulate spacer acquisition. In a complementary study by Datsenko et al. (2012) , mutation of cas1 or cas2 abolished phage M13 spacer incorporation, whereas overexpression of only cas1 and cas2 promoted acquisition (Datsenko et al., 2012 Strand-specific incorporation Cas1-3, Cascade-crRNA Leader Fig. 2 . Adaptation in the type I-E CRISPR-Cas system. (A) In naïve acquisition, infection with a phage that has not previously been encountered results in acquisition of a new spacer. The pre-spacer, including the final nt of the PAM, is acquired from the phage (dashed lines) and incorporated into the leader end of the array. The leader proximal repeat, with the exception of the final nt, is copied upon spacer incorporation (termed the duplicon) and the final nt of the PAM becomes the 3 0 nt of the repeat (yellow). Naïve acquisition requires Cas1 and Cas2. (B) During priming acquisition, the presence of a targeting crRNA against the original phage, or an escape mutant phage, leads to incorporation of new spacers in a strand-specific manner. This process requires Cas1, Cas2, Cascade-crRNA and Cas3.
In both cases, Cascade and Cas3 were not essential for spacer integration. Thus, these studies show that Cas1 and Cas2 are both necessary for acquisition, which is consistent with their dispensable role in crRNA maturation and interference in type I-E (Brouns et al., 2008) , type II-A (Deltcheva et al., 2011; Sapranauskas et al., 2011) and type III-A (Hatoum-Aslan et al., 2011) systems. These results are relevant to other CRISPR-Cas types because, as mentioned above, Cas1 and Cas2 are present in all systems (Makarova et al., 2006; Makarova et al., 2011b) . However, in other systems additional proteins may be involved. For example, an insertion mutation of csn2 inhibited spacer acquisition in the S. thermophilus type II-A system (Barrangou et al., 2007) .
The genetic studies described above proved unequivocally that Cas1 and Cas2 are necessary for spacer acquisition, but they did not reveal the exact mechanistic roles of these proteins. A number of biochemical and structural investigations provide an indication of the functions of Cas1 (Babu et al., 2011; Han et al., 2009; Wiedenheft et al., 2009 ) and Cas2 (Beloglazova et al., 2008; Nam et al., 2012a; Samai et al., 2010) . The first Cas1 protein to be studied biochemically was SSO1450 from S. solfataricus. The S. solfataricus Cas1 bound ss/dsDNA, ss/dsRNA and DNA-RNA hybrids with high-affinity ( 18-50 nM). In addition, Cas1 bound substrates containing CRISPR repeat and spacer sequences, but with no increase in affinity compared with unrelated sequences, demonstrating no apparent sequence specificity. The ability to promote the hybridization of single-stranded DNA strands was also proposed (Han et al., 2009) . In 2009, the crystal structure of the P. aeruginosa type I-F Cas1 was solved and was shown to be a Mn 2 þ or Mg 2 þ -dependent endonuclease, which cleaved dsDNA into short fragments of 80 bp (Wiedenheft et al., 2009 ). The predicted size of spacer substrates for integration in this system was 33 nt. Therefore, the 80 bp size of these Cas1-derived fragments was longer than expected, suggesting that other proteins, such as Cas2, may be required to process the 80 bp fragment to the correct size. The Pseudomonas Cas1 is a homodimer, which contains both a stirrup-like structure, approximately 20Å in diameter, and a positively charged surface that jointly were proposed to be involved in DNA binding (Wiedenheft et al., 2012) . The structure of the type I-E Cas1 from E. coli was subsequently solved and other structures are also available in the protein databank (PDB) (Babu et al., 2011) . E. coli Cas1 cleaved ssRNA and ss/dsDNA substrates and also resolved Holliday junctions, which are branched DNA intermediates important for DNA integration and recombination events. The non-specific binding of the different Cas1 proteins in these studies is consistent with a role in spacer acquisition, whereby the candidate pre-spacers that are sampled are of different sequence. If Cas1 is involved in generation of spacer substrates from candidate pre-spacers, the only sequence specificity that might be required is likely to be the PAM (see later), but this has yet to be examined at the biochemical level. The structures of several Cas2 proteins have also been solved and the proteins examined biochemically (Beloglazova et al., 2008; Nam et al., 2012a; Samai et al., 2010) . Cas2 from S. solfataricus consists of a ferredoxin-like fold and cleaved ssRNA at U-rich sequences (Beloglazova et al., 2008) . In contrast, when ssRNA or ssDNA binding or cleavage was assessed for Desulfovibrio vulgaris Cas2, no activity was observed (Samai et al., 2010) . A recent study demonstrated that the Bacillus halodurans Cas2 dimer was a Mg 2 þ -dependent dsDNA-specific endonuclease, which generated 120 bp fragments (Nam et al., 2012a) . These authors analyzed the known Cas2 structures and proposed that a loop region required for discrimination between RNA and DNA substrates would provide an explanation for the different activities of the characterized Cas2 proteins. The strict requirement of both Cas1 and Cas2 for the integration event in vivo (Datsenko et al., 2012; Yosef et al., 2012) , suggests that biochemical assays performed with proteins, candidate pre-spacer (with PAM) and leader-repeat substrates might be more revealing. We envisage that an integration-type protein/DNA complex mediates the adaptation stage.
One intriguing question about Cas1 and Cas2 is whether they function together directly via protein-protein interactions by analogy to the Cas complex formation that is required for type I and III interference. In Thermoproteus tenax, which contains a type I-A system, Cas1 and Cas2 are fused in a single protein, which interacts with both Cas4 and Csa1 (Plagens et al., 2012) . These four genes constitute an operon and the complex has been termed Cascis (CRISPR associated complex for the integration of spacers). These results strengthen the possibility that Cas4 and Csa1 are involved in the acquisition phase (Makarova et al., 2011a; Makarova et al., 2011b; Plagens et al., 2012) . In some CRISPRCas systems, Cas4 and Cas1 exist as a protein fusion, providing further evidence that they may function together in acquisition in the type I-A, I-B, I-C, I-D and II-B systems (Makarova et al., 2011a; Makarova et al., 2011b; van der Oost et al., 2009) . The role of Cascis in adaptation is uncertain, but it is interesting that a Cas1-Cas3 complex is also formed, which might be involved in the adaptation stage of type I-F systems (Richter et al., 2012a) . The Cas3 protein of the type I-F systems is a hybrid of Cas2-Cas3 and contains an N-terminal Cas2-like domain fused to Cas3 (Makarova et al., 2006; Makarova et al., 2011b; Richter et al., 2012a) . In contrast to these studies, a genome wide analysis in E. coli did not reveal protein-protein interactions between Cas1 and Cas2; however Cas1 interacted with Cas6e and Cas7 (Babu et al., 2011) , suggesting that variations likely exist between subtypes.
How are pre-spacers selected and added to arrays?
How do CRISPR-Cas systems selectively acquire foreign DNA from phages and plasmids for incorporation into CRISPR arrays? As mentioned earlier, research in S. thermophilus led to the identification of a short sequence adjacent to protospacers in the viral genomes, which was aptly named the protospacer adjacent motif (PAM) Mojica et al., 2009 ). Subsequently, an extensive bioinformatic approach identified the PAMs for many CRISPR-Cas systems (Mojica et al., 2009) . However, the requirement for PAMs in interference had precluded direct independent testing of their role in acquisition. In theory, phage challenge could result in random spacer acquisition, but yet only those that provide productive interference by targeting a viral protospacer with the correct PAM would survive the selection and be detected. Elegant experiments of spacer acquisition in the absence of interference by Yosef et al. (2012) refuted this theory and demonstrated that in E. coli, spacer selection requires a PAM. In E. coli, the PAM is three nt and in other CRISPR-Cas types PAMs are also only a few nt (Mojica et al., 2009) . The acquisition of chromosomally-derived spacers was rare relative to integration from the plasmid, even though a higher number of possible PAM targets existed in the chromosomal DNA . Therefore, despite a clear requirement of the PAM for integration, these data suggest that additional discrimination mechanisms must exist . What this mechanism(s) entails is a mystery, but it is possible that the presence or absence of some sort of DNA modification is detected. Alternatively, incorporation of chromosomally-derived spacers might be disfavored due to topological constraints between CRISPR arrays, Cas proteins and chromosomal pre-spacers during formation of an integration complex.
Once the spacer has been cut from the foreign DNA, presumably by either, or both, Cas1 and Cas2, what could be the remaining CRISPR requirements for spacer acquisition? In the type I-E system, a single 'repeat' and 60 bp of the leader 5 0 of the 'repeat' was sufficient for incorporation of a new repeat-spacer unit when Cas1 and Cas2 were expressed . The involvement of 60 bp of the leader suggests that this region contain sequences recognized by Cas1 and/or Cas2 (and possibly other host-derived factors) that are necessary for incorporation. In addition, it was observed that when the spacer is added to the expanding CRISPR array it delivers the last nt of the PAM, which becomes the most 3 0 nt of the leader proximal repeat ( Fig. 2A ) (Datsenko et al., 2012; Goren et al., 2012; Swarts et al., 2012) . This suggests that the nuclease(s) responsible (possibly Cas1 and/or Cas2) cleave the pre-spacer between the -1 and -2 nt of the PAM. The term 'duplicon' has been coined to explain this phenomenon, whereby only the initial 28 nt of the repeat are copied . It is tempting to speculate that the requirement for the leader and the PAM in incorporation provides the selectivity to enable incorporation of new spacers at the leader proximal end of the CRISPR array and in the correct orientation. However, the duplicon model whereby not the entire sequence of the repeat is copied, may not be a universal model applicable to all CRISPR-Cas systems. Erdmann and Garrett (2012) observed that the final nt of certain PAMs, such as the CCN in S. solfataricus, was not conserved and that spacers could be integrated in the wrong orientation. Lopez-Sanchez et al. (2012) also recently described the same observations in Streptococcus agalactiae.
Interestingly, transcription is not thought to be important for spacer acquisition by the type I-E system since the 60 bp of leader does not include the CRISPR promoter, yet still facilitates adaptation . Despite a single 'repeat' being sufficient for acquisition, this did not demonstrate which repeat is copied in a typical array containing multiple repeats. By analyzing two repeats with a single nt difference, it was demonstrated that the leader proximal repeat is duplicated when new spacers are inserted . Although Cas1 and Cas2 are shared among CRISPR-Cas systems, differences in repeats and other protein components will likely result in variations on a theme for spacer incorporation.
How do these systems kill viral escapees?
As explained earlier, spacer acquisition occurs against a virus not previously encountered; this can be considered naïve adaptation ( Fig. 2A) . However, from the work in E. coli, it is evident that adaptation can involve two steps; naïve-and priming-integration (i.e. the positive feedback loop) (Datsenko et al., 2012; Swarts et al., 2012) . In the process of priming (Fig. 2B) , the presence of the first spacer, with complementarity to the viral genome, enables the rapid acquisition of multiple spacers targeting that invader. Interestingly, there is an enrichment of spacers from the same DNA strand as the original spacer, suggesting that the targeting or binding promoted by this spacer is important for the generation of new incorporation substrates (Datsenko et al., 2012; Swarts et al., 2012) . By assessing priming in mutant strains, Datsenko et al. (2012) demonstrated that the entire Cas system is required (Cas1, Cas2, Cascade-crRNA and Cas3), but surprisingly, strains with spacers against viruses that have evaded targeting, due to single mutations in the protospacer or PAM, still displayed priming. What would be the advantage of this feedback system? Viruses or plasmids that have acquired point mutations to evade CRISPR-Cas targeting would quickly be detected and, through the integration of new spacers, these elements would be eliminated. Therefore, in the phage-bacterium arms race, CRISPR-Cas defense is less vulnerable to evasion by single point mutations than previously thought. Furthermore, the accumulation of multiple spacers against a single invader can strengthen resistance and reduce the probability of escape, as multiple mutations in the mobile element would be required.
Concluding remarks
Memorization of previous infections is a key characteristic of the CRISPR-Cas system that protects bacteria and archaea against foreign mobile genetic elements. Following infection, a short sequence of invading DNA is incorporated into the CRISPR array of the host genome, generating an ordered memory bank that directs the recognition of the same invaders upon repeated infection. Although the exact molecular mechanisms involved in adaptation are yet to be determined, recent studies have shown that both Cas1 and Cas2 are essential for acquisition and highlighted the critical requirement for the PAM sequence of the candidate pre-spacer (invading DNA) and the CRISPR leader sequence for integration of spacers. A number of questions remain to be addressed: Do Cas1 and Cas2 form a complex? How do they interact with the invader and what is the mechanism to integrate the spacer into the CRISPR array? Are protein(s) other than Cas1 and Cas2 involved in the naïve process of spacer acquisition? Are Cas1, Cas2, Cas3 and the CascadecrRNA complex the only components required for priming acquisition? Which conditions of infection are a trigger for priming? Are features other than the PAM involved in acquiring foreign DNA rather than self-DNA? The recent development of genetic strategies for studying the process of adaptation promise to reveal answers to many of these questions.
